May 11, 2022 / 08:20PM GMT
Derik De Bruin - BofA Securities, Research Division - MD of Equity Research
Welcome to the 2022 Bank of America Healthcare Conference. I'm Derik De Bruin, the Senior Life Sciences and Diagnostics Tools Analyst, also Biopharma Services. And thank you, everybody, for being here in beautiful Las Vegas. It's great to see so many people live and in person.
And our next company up is Charles River Labs. And with us is Birgit Girshick, Executive Vice President and COO of the organization. Thanks for being here.
Birgit Girshick - Charles River Laboratories International, Inc. - Corporate Executive VP & COO
Thank you.
Questions and Answers:
Derik De Bruin - BofA Securities, Research Division - MD of Equity ResearchThis is the first time that you and I have actually interacted in a venue like this. So big picture question. Because I'm basically an old man, I've covered Charles River since 2003. And when I was at lab, I was certainly a research model customer, really good quality mice. It's harder to make
Trustpilot
